Combined with the AstraZeneca's genomic medicine facility, the site will accommodate around 2,000 researchers and scientists.

Add Yahoo as a preferred source to see more of our stories on Google. A view of a helmet with the AstraZeneca logo next to a bust of former U.S. President Abraham Lincoln on the day of an announcement ...

Proposed $400bn tie-up with Bristol Myers Squibb would create world’s fourth-largest drugmaker but analysts question rationale More than £17bn was wiped off the value of Britain’s biggest drugmaker, ...

AstraZeneca has proudly awarded $3.4 million to nonprofit organizations in the US through its Accelerate Change Together (ACT) on Health Equity initiative. This effort aims to support programming that ...

AstraZeneca today announced the opening of its newest global strategic research and development (R&D) center, in Kendall Square, Cambridge, Massachusetts. The new state-of-the-art facility builds on ...

Add Yahoo as a preferred source to see more of our stories on Google. AstraZeneca has pulled Andexxa AstraZeneca has pulled its anticoagulant therapy, Andexxa (recombinant coagulation factor Xa), from ...

The US Food and Drug Administration (FDA) said on Friday it granted accelerated approval to AstraZeneca Plc’s breast cancer pill, expanding treatment options for adult patients with advanced breast ...

Recent US drug approvals and oncology milestones have put AstraZeneca back in the spotlight, while investors assess the pipeline’s potential and the stock’s role in the global pharma sector.

The British drugs company has ploughed £1.5bn into US pharma firm Summit Therapeutics as part of a cancer treatment research joint venture.

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has named Rick R. Suarez Senior Vice President, US President and Head of the US BioPharmaceuticals Business Unit. Suarez will lead the execution of the ...

A senior manager in AstraZeneca's US oncology unit alleges the company terminated him days after paying him the largest bonus ...